Abstract
Although one would predict that surfactant replacement therapy would be effective in acute respiratory distress syndrome (ARDS), a recent large trial proved unsuccessful, possibly reflecting the nature of the surfactant used. Given the importance of the unique proteins in the action of surfactant, these would seem vital components of any exogenous surfactant. The ability to identify patients at risk of ARDS and to characterise their surfactant might allow prophylactic treatment with a nebulised, complementary, tailor-made preparation of surfactant. Advanced cases might undergo bronchoscopic focal lavage to remove plasma proteins and inflammatory mediators prior to focal instillation of surfactant to areas of greatest need. Ventilation regimens might be adjusted both to minimise trauma and to conserve endogenous surfactant.
Full Text
The Full Text of this article is available as a PDF (109.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amato M. B., Barbas C. S., Medeiros D. M., Schettino G. de P., Lorenzi Filho G., Kairalla R. A., Deheinzelin D., Morais C., Fernandes E. de O., Takagaki T. Y. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1835–1846. doi: 10.1164/ajrccm.152.6.8520744. [DOI] [PubMed] [Google Scholar]
- Anzueto A., Baughman R. P., Guntupalli K. K., Weg J. G., Wiedemann H. P., Raventós A. A., Lemaire F., Long W., Zaccardelli D. S., Pattishall E. N. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30;334(22):1417–1421. doi: 10.1056/NEJM199605303342201. [DOI] [PubMed] [Google Scholar]
- Chu J., Clements J. A., Cotton E. K., Klaus M. H., Sweet A. Y., Tooley W. H., Bradley B. L., Brandorff L. C. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics. 1967 Oct;40(4 Suppl):709–782. [PubMed] [Google Scholar]
- Doyle I. R., Jones M. E., Barr H. A., Orgeig S., Crockett A. J., McDonald C. F., Nicholas T. E. Composition of human pulmonary surfactant varies with exercise and level of fitness. Am J Respir Crit Care Med. 1994 Jun;149(6):1619–1627. doi: 10.1164/ajrccm.149.6.8004321. [DOI] [PubMed] [Google Scholar]
- Gregory T. J., Longmore W. J., Moxley M. A., Whitsett J. A., Reed C. R., Fowler A. A., 3rd, Hudson L. D., Maunder R. J., Crim C., Hyers T. M. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 1991 Dec;88(6):1976–1981. doi: 10.1172/JCI115523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jobe A. H. Pulmonary surfactant therapy. N Engl J Med. 1993 Mar 25;328(12):861–868. doi: 10.1056/NEJM199303253281208. [DOI] [PubMed] [Google Scholar]
- Jobe A. H. Surfactant in the perinatal period. Early Hum Dev. 1992 Jun-Jul;29(1-3):57–62. doi: 10.1016/0378-3782(92)90058-o. [DOI] [PubMed] [Google Scholar]